Back to search
FDAFDA · Food and drugs·Recall number Z-0742-2013

Mindray DPM5 Monitor, a vital signs monitor used on human patients in healthcare facilities.

Published February 6, 2013 · Recall initiated: September 5, 2012

Summary

FDA records medical device Class II recall Z-0742-2013, published February 6, 2013 and initiated September 5, 2012. Recalling firm: Mindray DS USA, Inc. d.b.a. Mindray North America; Status: Terminated; Reported quantity: 13 units; Lot: p/n 9201F-PA000XX DS- 0C000565 02000335 12000603 12000599 12000597 OCOOO569 9A000247 9A000252 17000648 06000490 05000470 05000466 02000373. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Mindray has identified an issue with the DPM5 monitors where ST and Arrhythmia features may not be available.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mindray DS USA, Inc. d.b.a. Mindray North America
Distributor
US Nationwide Distribution including the states of: VA, TN, FL, & TX
Lot
p/n 9201F-PA000XX DS- 0C000565 02000335 12000603 12000599 12000597 OCOOO569 9A000247 9A000252 17000648 06000490 05000470 05000466 02000373
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Mindray DPM5 Monitor, a vital signs monitor used on human patients in healthcare facilities. recalled?

Yes. FDA published recall Z-0742-2013 on February 6, 2013. Reported hazard: Mindray has identified an issue with the DPM5 monitors where ST and Arrhythmia features may not be available.

What should I do if I have this product?

Voluntary: Firm initiated · Letter